Homozygosity for the C677 → T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e)ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden

Coronary Artery Disease

Volumn 12, Issue 2, 2001, Pages 85-90

  Thögersen, Anna Margrethe ^a,d   Nilsson, Torbjörn K ^a   Dahlen, Gösta ^a   Jansson, Jan Håkan ^b   Boman, Kurt ^b   Huhtasaari, Fritz ^c   Hallmans, Göran ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Skellefteå Hospital   (Sweden)

^c University of Technology   (Sweden)

^d Rigshospitalet   (Denmark)

Author keywords

Homocysteine; Methylenetetrahydrofolate reductase gene; Myocardial infarction; Risk factors

Indexed keywords

HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY RISK; ENZYME BLOOD LEVEL; FEMALE; GENE MUTATION; GENOTYPE; HEART INFARCTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SWEDEN; BLOOD; GENETICS; HOMOZYGOTE; MIDDLE AGED; PREVALENCE; RISK FACTOR; STATISTICAL MODEL;

CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HOMOZYGOTE; HUMANS; LOGISTIC MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN;

EID: 0034745480     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200103000-00001     Document Type: Article

References (35)

1. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation
2. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase
3. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease
4. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
5. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
6. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease
7. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes
8. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease
9. Molecular variant of 5,10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population
10. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation
11. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-contror study
12. Myocardiar infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene
13. A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction
14. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction
15. The 677C → T mutation in the methylenetetrahydrofolate reductase gene: Associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease
16. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease
17. A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction
18. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians
19. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. The Atherosclerosis Risk in Communities (ARIC) study
20. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
21. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis
22. Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction. An incident casecontrol study from northern Sweden
23. Cardiovascular risk factors in the Northern Sweden MONICA Study
24. Extraction of high quality genomic DNA from microsamples of human blood
25. Hardy-Weinberg equilibrium and the estimation of gene frequencies
26. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
27. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease
28. Serum total homocysteine and coronary heart disease
29. 6 and risk of myocardial infarction in US Physicians
30. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study
31. Plasma homocystein levels and mortarity in patients with coronary artery disease
32. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
33. Plasma homocystein in the acute and convalescent phases after stroke
34. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study
35. Why are diabetes, stomach cancer and circulatory diseases more common in northern Sweden?